The Motley Fool··Reuben Gregg BrewerMedtronic's FDA-Approved Hugo Robot Could Unlock Major Growth as Valuation Gap Widens
Medtronic ($MDT) wins FDA approval for Hugo surgical robot, trading at 27x P/E versus competitor Intuitive Surgical ($ISRG) at 64x, offering potential upside with 2.9% dividend yield.
MDTISRGgrowth opportunityvaluation